Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Monthly Martinique.
Press releases published on August 19, 2025
Zymeworks Announces Participation in Upcoming Investor Conferences
GlobeNewswire
·
August 19, 2025
VANCOUVER, British Columbia, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to- …
Greenwich LifeSciences Announces Plan to Build Out Internal Clinical Operations Team
GlobeNewswire
·
August 19, 2025
STAFFORD, Texas, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an immunotherapy …
ITM to Present New Subgroup Analysis Data from the COMPETE Trial at ESMO 2025 and Host an Educational Event for Healthcare Professionals
GlobeNewswire
·
August 19, 2025
Garching / Munich, Germany, August 19, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that further data on efficacy, safety and subgroup analysis from its recent Phase 3 COMPETE trial will be …
Scientists Discuss the Recent CancerVax Breakthrough
GlobeNewswire
·
August 19, 2025
Lehi, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Lehi, Utah, August 19, 2025 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform designed to use the body’s immune system to treat cancer, today announced the release of a video …
Basilea mit starkem Halbjahresergebnis 2025 auf Kurs
GlobeNewswire
·
August 19, 2025
Cresemba- und Zevtera-basierte Umsätze steigen um 24 % auf CHF 90.5 Mio. Gesamtumsatz steigt signifikant um 36 % auf CHF 104.0 Mio. Betriebsgewinn springt um 160 % auf CHF 24.0 Mio. Operativer Cashflow erhöht sich um 29 % auf CHF 23.1 Mio. Guidance für das …
Basilea on track with strong 2025 half-year results
GlobeNewswire
·
August 19, 2025
Cresemba® and Zevtera®-related revenues rise by 24% to CHF 90.5 million Total revenue grows significantly by 36% to CHF 104.0 million Operating profit surges by 160% to CHF 24.0 million Operating cash flow increases by 29% to CHF 23.1 million Full-year …
Santhera schließt Vereinbarung mit Uniphar über den Vertrieb von AGAMREE® (Vamorolon) in fünf Ländern des Golf-Kooperationsrats (GCC)
GlobeNewswire
·
August 19, 2025
Pratteln, Schweiz, 19. August 2025 – Santhera Pharmaceuticals (SIX: SANN) gibt die Unterzeichnung einer exklusiven Vereinbarung mit Uniphar über den Vertrieb von AGAMREE® (Vamorolon) in den Vereinigten Arabischen Emiraten, Saudi-Arabien, Kuwait, Oman und …
Santhera Secures Agreement with Uniphar for the Distribution of AGAMREE® (Vamorolone) in five GCC (Gulf Cooperation Council) Countries
GlobeNewswire
·
August 19, 2025
Pratteln, Switzerland, 19 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Uniphar to manage the distribution of AGAMREE® (vamorolone) in the United Arab Emirates, the Kingdom of Saudi Arabia, Kuwait, …
argenx to Host R&D Webinar Highlighting ARGX-119 on September 16, 2025
GlobeNewswire
·
August 19, 2025
August 19, 2025 Amsterdam, the Netherlands – argenx (Euronext …
CytoMed Therapeutics Limited Announces At-the-Market (ATM) Offering Program
GlobeNewswire
·
August 19, 2025
SINGAPORE, Aug. 18, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary technologies to develop novel donor blood- …